Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Inhibition of glycogen synthesis in rat hepatocytes by medium Zn/sup 2 +/

Journal Article · · Biochem. Biophys. Res. Commun.; (United States)

In hepatocytes from fasted rats, Zn/sup 2 +/ in the range from 0 to 500..mu..M has relatively minor effects on gluconeogenesis from most substrates, or on ureagenesis from NH/sub 3/. In hepatocytes from fed rats, Zn/sup 2 +/ does not affect glycogenolysis. In hepatocytes from fasted rats, in which glycogen is being actively synthesized using the substrate combination of glycose, lactate and glutamine (all 10mM), Zn/sup 2 +/ markedly inhibits glucogen synthesis, with total inhibition at 500..mu..M, and a half maximal effect in the range from 50 to 100..mu..M. Dipicolinate (pyridine 2,6-dicarboxylate), a zinc chelator, is about as effective as L-glutamine in activating glycogen synthesis with the substrate combination of dihydroxyacetone, lactate and glucose (all 10mM). This suggests the possible hypothesis that endogenous Zn/sup 2 +/ might control the rate of glycogen synthesis in vivo. However, alternate explanations such as metabolite accumulation are also possible, since dipicolinate causes inhibition of gluconeogenesis from L-lactate. 28 references, 3 tables.

Research Organization:
Cedars-Sinai Medical Center, Los Angeles, CA
OSTI ID:
5970100
Journal Information:
Biochem. Biophys. Res. Commun.; (United States), Journal Name: Biochem. Biophys. Res. Commun.; (United States) Vol. 122:2; ISSN BBRCA
Country of Publication:
United States
Language:
English